Cellcept and Butrans drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Butrans (buprenorphine). Common drug interactions include infective pulmonary exacerbation of cystic fibrosis among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Butrans. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Butrans?

Butrans has active ingredients of buprenorphine. It is often used in pain. eHealthMe is studying from 64,148 Butrans users. Check the latest studies of Butrans.

On Aug, 11, 2026

11 people who take Cellcept and Butrans together, and have interactions are studied.

What are the common drug interactions of Cellcept and Butrans, by gender? *:

female:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Cataract (clouding of the lens inside the eye)
Cough
Diarrhoea
Memory impairment
Nerve injury
Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
Somnolence (a state of near-sleep, a strong desire for sleep)
Amylase increased
Application site burn

male:

Abdominal pain
Abdominal pain upper
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Hypophagia (reduced food intake)
Hypotension (abnormally low blood pressure)
Immune system disorder
Nausea (feeling of having an urge to vomit)
Osteomyelitis (infection of bone)
Peripheral ischaemia (impaired circulation to an extremity)
Post procedural complication

What are the common drug interactions of Cellcept and Butrans, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Amylase increased
Blood pressure increased
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Decreased appetite
Dry eye (lack of adequate tears)
Fall
Foot fracture
Fracture
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)

50-59:

Application site burn
Application site exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface)
Application site pruritus (application site severe itching of the skin)
Application site vesicles (small bubble within a cell at application site)
Immune system disorder
Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
Skin disorder (skin disease)

60+:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Cataract (clouding of the lens inside the eye)
Dehydration (dryness resulting from the removal of water)
Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
Fatigue (feeling of tiredness)
Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Hypophagia (reduced food intake)
Hypotension (abnormally low blood pressure)
Immune system disorder

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 3 people, 27.27%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 18.18%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 9.09%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
High Blood Pressure: 1 person, 9.09%
Hereditary Angioedema (recurrent episodes of severe swelling): 1 person, 9.09%
Hepatocellular Carcinoma (liver cancer): 1 person, 9.09%
Growth Hormone Deficiency: 1 person, 9.09%
Body Height Below Normal: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Butrans?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously